# Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy

> **NCT03165188** · — · TERMINATED · sponsor: **NewLink Genetics Corporation** · enrollment: 29 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03165188
- **Lead sponsor:** NewLink Genetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-01
- **Primary completion:** 2020-12-08
- **Final completion:** 2020-12-08
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** The IND was withdrawn
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03165188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03165188, "Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03165188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*